Viewing Study NCT00924092

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:44 PM
Ignite Modification Date: 2026-01-05 @ 6:34 PM
Study NCT ID: NCT00924092
Status: COMPLETED
Last Update Posted: 2019-12-12
First Post: 2009-06-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ...
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
None Breast Cancer View
None Lung Cancer View
None Colorectal Cancer View
None Head and Neck Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunotherapy View
None Lung Cancer View
None Colorectal Cancer View
None Head and Neck Cancer View
None Prostate View
None Breast Cancer View